drugset / Trial / NCT00817050

Single Dose Crossover Study of Patient Preference for Unscented Nasonex® Nasal Spray Versus Scented Flonase® Nasal Spray (Study P04207)

NCT00817050

Phase 4 Completed 100 enrolled Organon and Co
RandomizedCrossoverQuadruple-blindTreatment

Summary

This was a one-day single dose trial conducted to compare patient's preference for Nasonex® (mometasone) versus Flonase® nasal spray. Each patient was randomized to take one dose (2 sprays in each nostril) of Nasonex or Flonase. Thirty minutes later, each patient was to take one dose of the opposite medication. Questionnaires were given to each patient after each drug dose to evaluate patient product preference.

Timeline

Start
2004-12-01
Primary completion
2005-01-01
Completion
2005-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Other / unclassified 2 unknown Other
Comparator Mometasone furoate Other / unclassified 2 unknown Other

Indications